Starling Oncology, Inc. (STLN) · Peers
Starling Oncology against the 9 other companies here in its SEC industry, Services-Offices & Clinics Of Doctors Of Medicine. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 10, highest first.
Measure by measure
| Measure | STLN | Peer median | Rank |
|---|---|---|---|
| Market value | $655.32M | median $110.86M | 3 of 10 |
| P/S | 1.1× | median 0.7× | 5 of 10 |
| FCF yield | -0.5% | median -8.2% | 5 of 10 |
| Operating margin | -4.4% | median -7.9% | 3 of 9 |
| Net margin | -6.2% | median -7.8% | 4 of 10 |
| ROIC | -148.2% | median -10.7% | 7 of 7 |
| Revenue growth (4y, yearly) | 25.4% | median 4.0% | 2 of 8 |
| Current ratio | 1.4× | median 0.9× | 2 of 10 |
| Stock pay / revenue | 0.9% | median 2.3% | 7 of 10 |
| Share count change | 23.1% | median 6.7% | 2 of 10 |
Green where Starling Oncology is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| STLNStarling Oncology, Inc. | $655.32M | P/E – | -148.2% | 4.8 |
| HIMSHims & Hers Health, Inc. | $6.51B | P/E – | -14.4% | 4.9 |
| TDOCTeladoc Health, Inc. | $1.03B | P/E – | -27.5% | 6.8 |
| SBCSBC Medical Group Holdings Inc | $530.69M | P/E 10.8× | 44.0% | 7.5 |
| CCMConcord Medical Services Holdings Ltd | $451.32M | P/E – | -22.5% | 3.0 |
| LFMDLifeMD, Inc. | $110.86M | P/E 551.5× | – | 4.9 |
| AIRSAirsculpt Technologies, Inc. | $91.92M | P/E – | -7.1% | 3.1 |
| BMGLBasel Medical Group Ltd | $6.18M | P/E – | – | 3.5 |
| HLYKHealthLynked Corp | $6.17M | P/E – | – | 2.5 |
| CDIXCardiff Lexington Corp | $734,956 | P/E – | 3.6% | 3.2 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.